DaVita (DVA) Sees Q3 EPS Above Views; Boosts FY11 Operating Income Outlook
Get Alerts DVA Hot Sheet
Price: $173.82 -0.81%
Financial Fact:
Depreciation and amortization: 181.74M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Depreciation and amortization: 181.74M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
DaVita Inc. (NYSE: DVA) reports estimates for certain third quarter 2011 operating results in advance of the announcement of its actual third quarter operating results, which is expected to occur after market close on November 3, 2011. Our estimate of operating results for the third quarter of 2011 includes:
- Operating income in the range of $314 million to $322 million.
- Diluted earnings per share from continuing operations in the range of $1.43 to $1.48. The Street sees EPS of $1.29.
- Normalized non-acquired treatment growth of approximately 4.6%.
- Continued deterioration in our mix of treatments reimbursed by non-government payors as a percentage of total treatments.
- Operating results of DSI beginning September 1, 2011
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share